0001530766-14-000003.txt : 20140417 0001530766-14-000003.hdr.sgml : 20140417 20140417120700 ACCESSION NUMBER: 0001530766-14-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140417 DATE AS OF CHANGE: 20140417 EFFECTIVENESS DATE: 20140417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-215799 FILM NUMBER: 14769278 BUSINESS ADDRESS: STREET 1: 12424 WILSHIRE BOULEVARD STREET 2: SUITE 745 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310-820-8100 MAIL ADDRESS: STREET 1: 12424 WILSHIRE BOULEVARD STREET 2: SUITE 745 CITY: LOS ANGELES STATE: CA ZIP: 90025 D 1 primary_doc.xml X0707 D LIVE 0001530766 BioSig Technologies, Inc. 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 310-820-8100 DELAWARE None None Corporation true 2011 Kenneth Londoner 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Director Jonathan Steinhouse 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Asher Holzer 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Roy Tanaka 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Kalyanam Shivkumar 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Seth Fischer 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Steve Chaussy 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Chief Financial Officer Biotechnology Decline to Disclose 06b false 2014-04-04 false true true false 0 Laidlaw & Company (UK) Ltd. 119037 None None 546 5th Avenue, 5th Floor New York NY NEW YORK 10036 MA MASSACHUSETTS NY NEW YORK TX TEXAS WV WEST VIRGINIA true 5000000 204900 4795100 false 6 20490 0 The Issuer also issued a five-year warrant to purchase 8,196 shares of common stock at an exercise price of $3.75 per share to the placement agent as consideration for serving as the placement agent. 0 false BioSig Technologies, Inc. Kenneth Londoner Kenneth Londoner Executive Chairman 2014-04-17